Experience
-
UCB (8 yrs 2 mos)
-
VP, Asset Head - Ultra-Rare
Aug 2024 - Present · 2 yrs
Accountable for maximizing the value of an asset in ultra rare accross the entire ecosystem, including development of the lead indication, life cycle management, launch in the main territories, geographical expension, maufacturing and supply chain
-
Head of Development - Ultra Rare
Mar 2022 - Aug 2024 · 2 yrs 6 mos
Heading UCB's development portfolio in mitochondrial disease and ultra-rare diseases
-
Global Clinical Development Therapeutic Area Head - Immunology
Apr 2021 - Aug 2024 · 3 yrs 5 mos
-
Patient Experience Work Stream Co-Lead at TransCelerate BioPharma Inc.
Oct 2016 - Nov 2020 · 4 yrs 2 mos
-
Allergan (5 yrs 5 mos)
-
Executive Director, Clinical Development
Jan 2017 - May 2018 · 1 yr 5 mos
-
Sr Director Clinical, Development
Mar 2016 - Jan 2017 · 11 mos
-
Director Clinical Development
Feb 2015 - Mar 2016 · 1 yr 2 mos
-
Head of Clinical Affairs at Uteron Pharma SA
Feb 2012 - Dec 2012 · 11 mos
-
Baxter International Inc. (11 yrs 1 mo)
-
Associate Director, Clinical Affairs
2010 - Jan 2012 · 2 yrs 1 mo
-
Senior Manager, Clinical Affairs
2010 - 2011 · 1 yr
-
Manager, Clinical Services
2007 - 2010 · 3 yrs